Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.
about
Micrometastases in neuroblastoma: are they clinically important?Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrowUse of tumor-specific gene expression for the differential diagnosis of neuroblastoma from other pediatric small round-cell malignancies.Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma.Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastomaCirculating clonotypic B cells in classic Hodgkin lymphomaCellular kinetics of neuroblastoma and the role of surgery.Standardization of the immunocytochemical detection of neuroblastoma cells in bone marrow.Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells.Expression of Wilms tumor gene in high risk neuroblastoma: complementary marker to tyrosine hydroxylase for detection of minimal residual disease.Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.Neuroblastoma initially presenting as a primary bone tumor: diagnostic value of molecular assays for tyrosine hydroxylase.Detection of disseminated prostate cells by reverse transcription-polymerase chain reaction (RT-PCR): technical and clinical aspects.Static micro-array isolation, dynamic time series classification, capture and enumeration of spiked breast cancer cells in blood: the nanotube-CTC chip.Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma.PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers - Focus on neuroblastoma.Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results.
P2860
Q35615459-5CBCF603-B77C-4841-9806-30BB57829B3BQ35747067-2C03E543-7F3A-40B7-8BE3-F9EDC9B67638Q35787273-6D7D061A-85B5-4125-8ACE-FF69965BB8CEQ35789588-18331360-FD41-49AD-8CC3-F114F152638DQ36421938-27ED3128-654F-4C79-B79B-FB7BFA0403FDQ37237474-6EBD6CDD-7297-4649-8FC4-57FD929A7CEAQ37902576-89036678-69B8-4B35-A05B-AF88D2692953Q38318142-2D16EE77-71A3-4A24-8A68-8D9567BD5035Q41465370-C96A4BB9-4F38-4FAC-AC2D-A7A32C98DC5AQ41873710-82601533-521F-40B2-A4B3-959AB686C835Q43066010-4A1C66ED-9A24-4A43-A0B7-1A573303091BQ43682574-52204980-B9E1-4473-86D6-7ED416666EFFQ44272414-202DC572-CD09-4D8C-A44A-BC40051ECCE9Q47751202-67556449-C1C7-4DDC-B650-A94F852F52DFQ51151625-2C540BF3-3E00-4434-8994-F74CB753E2A9Q51768675-7E48F1F9-27BC-4840-A0BA-7BBEF192403DQ52816741-5D7BD925-B2F0-408B-A279-B19CEC8BBB45Q53319588-EA8F9A47-90B9-4B4F-8A15-DB6571FE6888
P2860
Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Detection of neuroblastoma cel ...... for tyrosine hydroxylase mRNA.
@en
type
label
Detection of neuroblastoma cel ...... for tyrosine hydroxylase mRNA.
@en
prefLabel
Detection of neuroblastoma cel ...... for tyrosine hydroxylase mRNA.
@en
P2093
P1433
P1476
Detection of neuroblastoma cel ...... for tyrosine hydroxylase mRNA.
@en
P2093
P304
P356
10.1002/1097-0142(19950601)75:11<2757::AID-CNCR2820751120>3.0.CO;2-S
P407
P577
1995-06-01T00:00:00Z